Rebus Holdings, Inc.
Rebus Holdings, Inc. (RBSH) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
rbsh · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Rebus Holdings, Inc.You RBSH | $0M | N/A | — | -$0.03 |
 Anthera Pharmaceuticals, Inc. ANTH | $0M | N/A | — | -$1.65 |
 Comera Life Sciences Holdings, Inc. CMRA | $0M | N/A | — | -$1.72 |
 FluoroPharma Medical, Inc. FPMI | $0M | N/A | — | -$0.06 |
 GlobeImmune, Inc. GBIM | $0M | N/A | — | -$0.48 |
 New Leaf Ventures Inc NLVVF | $0M | N/A | — | -$0.29 |
 Neurobiological Technologies, Inc. NTII | $0M | N/A | — | $0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Rebus Holdings, Inc. (RBSH) measures how much investors pay for each dollar of the company's trailing earnings. RBSH's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.03.
Frequently asked questions
RBSH pe ratio · 6 questionsRBSH's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.03. Data sourced from Financial Modeling Prep via RBSH's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Rebus Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09